198 related articles for article (PubMed ID: 15995155)
1. Sleep disturbance and depression as barriers to adherence.
Phillips KD; Moneyham L; Murdaugh C; Boyd MR; Tavakoli A; Jackson K; Vyavaharkar M
Clin Nurs Res; 2005 Aug; 14(3):273-93. PubMed ID: 15995155
[TBL] [Abstract][Full Text] [Related]
2. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
Webb MS; Vanable PA; Carey MP; Blair DC
AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
Tadios Y; Davey G
Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
[TBL] [Abstract][Full Text] [Related]
4. The impact of HIV diagnosis-related vs. non-diagnosis related trauma on PTSD, depression, medication adherence, and HIV disease markers.
Boarts JM; Buckley-Fischer BA; Armelie AP; Bogart LM; Delahanty DL
J Evid Based Soc Work; 2009 Jan; 6(1):4-16. PubMed ID: 19199133
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
[TBL] [Abstract][Full Text] [Related]
6. Predicting adherence to antiretroviral therapy in HIV-infected older adults: the moderating role of gender.
Bianco JA; Heckman TG; Sutton M; Watakakosol R; Lovejoy T
AIDS Behav; 2011 Oct; 15(7):1437-46. PubMed ID: 20632080
[TBL] [Abstract][Full Text] [Related]
7. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
Villes V; Spire B; Lewden C; Perronne C; Besnier JM; Garré M; Chêne G; Leport C; Carrieri MP; Le Moings V;
Antivir Ther; 2007; 12(7):1067-74. PubMed ID: 18018765
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.
Dalessandro M; Conti CM; Gambi F; Falasca K; Doyle R; Conti P; Caciagli F; Fulcheri M; Vecchiet J
J Clin Psychopharmacol; 2007 Feb; 27(1):58-61. PubMed ID: 17224714
[TBL] [Abstract][Full Text] [Related]
9. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
[TBL] [Abstract][Full Text] [Related]
10. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease.
Bane C; Hughes CM; McElnay JC
Patient Educ Couns; 2006 Feb; 60(2):187-93. PubMed ID: 16253468
[TBL] [Abstract][Full Text] [Related]
11. Physiological and psychological correlates of fatigue in HIV disease.
Phillips KD; Sowell RL; Rojas M; Tavakoli A; Fulk LJ; Hand GA
Biol Res Nurs; 2004 Jul; 6(1):59-74. PubMed ID: 15186708
[TBL] [Abstract][Full Text] [Related]
12. Bereaved caregivers' descriptions of sleep: impact on daily life and the bereavement process.
Carter PA
Oncol Nurs Forum; 2005 Jul; 32(4):741. PubMed ID: 15990901
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
[TBL] [Abstract][Full Text] [Related]
14. The influence of symptoms on quality of life among HIV-infected women.
Hudson A; Kirksey K; Holzemer W
West J Nurs Res; 2004 Feb; 26(1):9-23; discussion 24-30. PubMed ID: 14984639
[TBL] [Abstract][Full Text] [Related]
15. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M; Koffi CK
AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.
Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S
Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167
[TBL] [Abstract][Full Text] [Related]
17. Sleep disturbances among HIV-positive adults: the role of pain, stress, and social support.
Vosvick M; Gore-Felton C; Ashton E; Koopman C; Fluery T; Israelski D; Spiegel D
J Psychosom Res; 2004 Nov; 57(5):459-63. PubMed ID: 15581649
[TBL] [Abstract][Full Text] [Related]
18. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
[TBL] [Abstract][Full Text] [Related]
19. Literacy, self-efficacy, and HIV medication adherence.
Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
[TBL] [Abstract][Full Text] [Related]
20. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
